INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed Sep 23, 2015
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Sale
Common Stock
2015-09-21$194.82/sh−973$189,560→ 962 total - Exercise/Conversion
Common Stock
2015-09-21$9.82/sh+973$9,557→ 1,935 total - Exercise/Conversion
Options to Purchase Common Stock
2015-09-21−973→ 2,921 totalExercise: $9.82Exp: 2019-09-16→ Common Stock (973 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
- [F2]All shares underlying this option have vested.